Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting

Completed · Not applicable

Conditions studied: Social Anxiety Disorder, Alcohol Use Disorders

In brief

The purpose of this study is to treat individuals with social anxiety disorder with a Food and Drug Administration-approved medication for the treatment of social anxiety disorder, the antidepressant paroxetine, and to evaluate the impact of an intervention designed to help those individuals cope with anxiety without the use of common coping behaviors.

Key facts

Study ID
NCT00862212
Run by
Medical University of South Carolina
People needed
83
Starts
2009-01-01
Expected to finish
2012-07-01
Last updated by the study team
2013-04-23

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.